Anthony Donaghue, Author at Born2Invest

Anthony Donaghue

Anthony Donaghue writes about science and technology. Keeping abreast of the latest tech developments in various sectors, he has a keen interest on startups, especially inside and outside of Silicon Valley. From time to time, he also covers agritech and biotech, as well as consumer electronics, IT, AI, and fintech, among others. He has also written about IPOs, cannabis, and investing.

Born2Invest uses cookies in order to improve your experience and make further customizations to how we present our content. By continuing to use our website, you accept and give your consent to our practices as described in the following: our revised Privacy Policy, Cookie Policy, and Terms of Use.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Born2Invest

Anthony Donaghue

Stories By Anthony Donaghue

Neki boosts its momentum in 2020 and expects a turnover of 1 million in 2021

Strategic acquisition in the German fintech sector

Lyon-based biotech company genOway announces strong revenue growth for 2020

DeepTrace Technologies: 1.7 million round for AI-based radiological imaging startup

New Born Solutions closes a round of €600,000 for clinical validation

Ruti Immune closes a €1.6 million round to advance against COVID-19

The health sector in Spain attracts 140 million in investments

Tractivus seeks 2.3 million to carry out the clinical validation of its technology

Inbentus needs half a million euros to advance the development of respirators

Mediquo enters the Argentine public health system